Developers: | AngioDynamics |
Date of the premiere of the system: | September, 2020 |
Branches: | Pharmaceutics, medicine, health care |
2020: Auryon start - the systems of treatment of diseases of peripheral arteries
At the end of September, 2020 the AngioDynamics company released the system of a laser aterektomiya Auryon for treatment of diseases of peripheral arteries. A system can be used for treatment of occlusions and defeats of any type and extent as above, and below a knee with the minimum impact on walls of vessels. The scope of a new system includes critical ischemia of extremities and restenoz in the stent.
In a system the platform which sends short ultra-violet laser impulses with the wavelength of 355 nanometers is used. A system tries to obtain target biological reactions from a vessel wall, minimizing risk of perforation, an embolization or other serious complications. Besides, it provides evaporation of defeats without thermal ablation.
Clinical trials showed that the technology which is the cornerstone of the system of an aterektomiya Auryon is effective at treatment of both soft plaques, and strongly calcific, and is capable to save life and to prevent amputation to a great number of patients to whom other options of treatment are unavailable. During the main research at one of patients signs of a restenoz in half a year after treatment were not noted.
AngioDynamics developers also reported that the Auryon system is supplied with functions of aspiration and shift at certain sizes of catheters therefore doctors can reduce risk of an embolization at treatment of all types of defeats.
We firmly believe that the system of an aterektomiya Auryon will be able cardinally to change rules of treatment of diseases of peripheral arteries. It is serious technology progress in treatment of such widespread and potentially deadly statuses, - the president and the CEO of AngioDynamics Jim Clemmer noted. - We already received very grateful response from the first users of the Auryon system.[1] |